Novavax Vaccine | Covid-19 Vaccine

 Novavax Vaccine

Novavax has been shown to be highly effective in clinical trials. The Novavax vaccine may be a protein adjuvant. it's simpler to form than a number of the opposite vaccines and may be stored during a refrigerator, making it easier to distribute. Novovax has studied its vaccine together with the influenza vaccine with positive results.
Not available within the U.S. at this point , but could become available in several other countries toward the top of this year and early next year.
Recommended for people ages 12-84.
2 doses, three weeks apart.

Working Method:

Unlike the mRNA and vector vaccines, Novavax vaccine is often a protein adjuvant (an adjuvant is an ingredient wont to strengthen the immune response). While other vaccines trick the body’s cells into creating parts of the virus which will trigger the system , the Novavax vaccine takes a special approach. It contains the spike protein of the coronavirus itself, but formulated as a nanoparticle, which cannot cause disease. When the vaccine is injected, this stimulates the system to supply antibodies and T-cell immune responses.

Efficiency: 

90% effective against lab-confirmed, symptomatic infection and 100% against moderate and severe disease in Phase 3 trial results released during a company statement in June. the corporate says the vaccine was 91% protective of individuals in high-risk populations like people older than 65, those with health conditions that increase risk of complication, and people in situations where they're frequently exposed to the virus.

Novavax says the vaccine is 93% effective against “predominantly circulating variants of concern and variants of interest.” But it’s important to notice that the study was conducted within the U.S. and Mexico, when Alpha was the predominant strain within the U.S., although other variants were on the increase . More data is required to work out the effectiveness of Novavax against the Delta variant.

Side Effects:

Injection site tenderness, fatigue, headache, muscle pain.

More Detail.....

Read More

AstraZeneca Vaccine | COVID-19 Vaccine Detail

 AstraZeneca 

Vaccine

This vaccine, which is currently being distributed within the uk and other countries, is distinguished from a number of its competitors by its lower cost—it’s cheaper to form per dose, and while a number of the opposite vaccines must be stored frozen, this one are often stored in normal refrigeration for a minimum of six months, making it easier to distribute.
Not available within the U.S., authorized for emergency use in other countries, including within the European Union (under the name Vaxzevria) and therefore the uk .
Recommended for Adults 18 and older
Two doses 4 to 12 weeks apart.

Working Method:

Similar to the Johnson & Johnson vaccine, this is often a carrier vaccine. Scientists engineer a harmless adenovirus as a shell to hold ordering on the spike proteins to the cells. Once the code is inside the cells, the cells produce a spike protein to coach the body’s system , which creates antibodies and memory cells to guard against an actual SARS-CoV-2 infection.

Efficiency: 

AstraZeneca updated its data analysis of its phase 3 trials in March, showing its vaccine to be 76% effective at reducing the danger of symptomatic disease 15 days or more after receiving the 2 doses, and 100% against severe disease. the corporate also said the vaccine was 85% effective in preventing COVID-19 in people over 65. The company’s update came a couple of days after the National Institute for Allergy and Infectious Diseases (NIAID) expressed concern over data AstraZeneca had submitted beforehand of requesting an EUA from the FDA. The NIAID said that data may have included outdated information, which might make its efficacy data incomplete. 

So far it seems to figure better against the Alpha variant than the Beta variant. A paper in early February (not yet peer-reviewed) cited 74.6% efficacy against the Alpha variant. However, the vaccine didn't protect also against mild and moderate cases in people infected with the Beta variant.

Therefore, South Africa halted its roll out while scientists still study whether the vaccine can prevent severe illness and death in people infected with this variant. As far because the Delta variant, two recent studies (neither has been peer-reviewed) showed, respectively, that full vaccination after two doses is 60% effective against symptomatic disease and 93% effective against hospitalization.

Side Effects:

Tenderness, pain, warmth, redness, itching, swelling or bruising at the injection site, all of which generally resolve within each day or two.

Some countries temporarily suspended use of this vaccine in March after a little number of recipients developed blood clots and a few died. In April, a EU Medicines Agency (EMA) safety committee concluded "unusual blood clots with low blood platelets should be listed as very rare side effects" that would occur within fortnight of receiving the vaccine, and stressed that the advantages still outweigh the risks. In July, a study by the drugmaker, published within the Lancet, estimated the speed of thrombosis with thrombocytopenia syndrome, a clotting disorder, at 8.1 cases per million in those that received a primary dose of the vaccine, and 2.3 per million after the second dose, which is like incidence within the general population.

More Detail.....

Read More

Johnson & Johnson Vaccine | Covid-19 vaccine detail and how it work

 Johnson & Johnson

 Vaccine

The FDA granted emergency use authorization for Johnson & Johnson’s vaccine in February 2021. Unlike the Pfizer and Moderna vaccines, this is often a carrier, or virus vector, vaccine. It are often stored in normal refrigerator temperatures, and since it requires only one shot, it's easier to distribute and administer. (In November of 2020, Johnson & Johnson announced it might launch a second Phase 3 clinical test to review using two doses, two months apart, to ascertain if that regimen would offer better protection.)

Emergency use within the U.S. and other countries, including within the European Union (under the name Janssen).
Recommended for: Adults 18 and older.
Single shot. Fully effective fortnight after vaccination.

Working Method:

This is a carrier vaccine, which uses a special approach than the mRNA vaccines to instruct human cells to form the SARS CoV-2 spike protein. Scientists engineer a harmless adenovirus (a common virus that, when not inactivated, can cause colds, bronchitis, and other illnesses) as a shell to hold ordering on the spike proteins to the cells (similar to a Trojan Horse). The shell and therefore the code can’t cause you to sick, but once the code is inside the cells, the cells produce a spike protein to coach the body’s system , which creates antibodies and memory cells to guard against an actual SARS-CoV-2 infection.

Efficiency: 

72% overall efficacy and 86% efficacy against severe disease within the U.S., consistent with analyses posted by the FDA in February. In August, the corporate announced that new data showed a booster at six months had a rapid and robust nine-fold increase in spike-binding antibodies in volunteers compared to twenty-eight days after their first dose. That data has not yet been peer-reviewed or published during a scientific journal.

Side Effect:

Fatigue, fever headache, injection site pain, or myalgia (pain during a muscle or group of muscles), all of which generally resolve within each day or two. it's had noticeably milder side effects than the Pfizer and Moderna vaccines, consistent with the FDA report released in late February. nobody suffered an allergy in clinical trials for the vaccine, consistent with the corporate .

The FDA has attached two warnings to the Johnson & Johnson vaccine. In July, the FDA attached a warning after rare cases of the nervous disorder Guillain-Barre syndrome were reported during a small number of vaccination recipients. Most of the cases occurred within 42 days after vaccination.

In April, the FDA added a warning label after ending an interruption on the vaccine it had recommended “out of an abundance of caution” over an uncommon, but potentially serious, blood coagulation disorder that occurred during a small number of recipients.

Work on Virus Mutations:

Johnson & Johnson reported in July that its vaccine is additionally effective against the Delta variant, showing only alittle drop by potency compared with its efficacy against the first strain of the virus, although one recent studysuggested that the J&J vaccine is a smaller amount effective against Delta.

But the primary study to assess the vaccine against Delta within the world reported the vaccine to be 71% effective against hospitalization and up to 95% effective against death. The vaccine’s performance was slightly lower against the Beta variant within the study. This preliminary research was reported in August at a press conference by the Ministry of Health in South Africa . These studies haven't yet been peer-reviewed or published during a scientific journal.

More Detail.....

Read More

Moderna Vaccine | Covid-19 Vaccine detail

 MODERNA   VACCINE

Moderna vaccine was authorised for emergency use within the U.S. last December, a few week after the Pfizer vaccine. Moderna uses an equivalent mRNA technology as Pfizer and features a similarly high efficacy at preventing symptomatic disease. It also must be stored in freezer-level temperatures.

In mid-August, the FDA approved a booster of the Moderna vaccine surely immuno-compromised individuals, including solid transplant recipients and people with conditions that give them an equally reduced ability to fight infections and other diseases. 
Emergency use within the U.S and other countries, including within the European Union (it’s been approved in Switzerland) and other countries.

Adults 18 and older. While the vaccine isn't yet available for youngsters , the corporate says its vaccine provides strong protection for youngsters as young as 12, and it's testing its efficacy for youngsters ages 5-11.Two shots, 28 days apart; fully effective fortnight after the second dose.

Working:

Similar to the Pfizer vaccine, this is often an mRNA vaccine that sends the body’s cells instructions for creating a spike protein which will train the system to acknowledge it. The system will then attack the spike protein subsequent time it sees one

Effectiveness:

Greater than 90% efficacy against cases of COVID-19 and quite 95% against severe cases, with approximately 6 months median follow-up after the second dose, consistent with the corporate . Earlier Phase 3 studies showed Moderna to be 94.1% effective at preventing symptomatic infection in people with no evidence of previous COVID-19 infection (although the efficacy rate drops to 86.4% for people ages 65 and older).

In late March, alittle CDC study that enrolled 3,950 health care personnel, first responders, and other essential and frontline workers showed the vaccine to be 90% effective upon full immunization (at least 14 days after the second dose) in real-world conditions.

In August, the CDC also published studies that showed mRNA vaccine protection against infection could also be waning, although the vaccines were still highly effective against hospitalization. In one CDC study, data from the state of latest York showed vaccine effectiveness dropping from 91.7 to 79.8% against infection.

Side Effects: 

Similar to Pfizer, side effects can include chills, headache, pain, tiredness, and/or redness and swelling at the injection site, all of which generally resolve within each day or two. On rare occasions, mRNA vaccines have seemed to trigger anaphylaxis, a severe reaction that's treatable with epinephrine. For that reason, the CDC requires vaccination sites to watch everyone for quarter-hour after their COVID-19 shot, and for half-hour if they need a history of severe allergies. 

The FDA placed a warning label on the Moderna vaccine regarding a “likely association” with reported cases of heart inflammation in young adults. This inflammation may occur within the cardiac muscle (myocarditis) or within the outer lining of the guts (pericarditis), and is taken into account important but uncommon—arising in about 12.6 cases per million second doses administered. The inflammation, in most cases, gets better on its own without treatment.

More Detail...

Read More

Pfizer Vaccine Detail | COVID-19 Vaccine information

 Pfizer Vaccine

In August 2021, Pfizer-BioNTech became the primary COVID-19 vaccine to receive full approval for people ages 16 and older from the Food and Drug Administration (FDA) to be used within the U.S. In December, it had been the primary COVID-19 vaccine to receive FDA Emergency Use Authorization (EUA), after the corporate reported positive initial clinical test data that showed the vaccine was highly effective at preventing symptomatic disease. this is often a messenger RNA (mRNA) vaccine, which uses a comparatively new technology. It must be stored in freezer-level temperatures, which may make it harder to distribute than another vaccines.

In mid-August, the FDA authorized a booster of the Pfizer vaccine surely immuno-compromised individuals, including solid transplant recipients and people with conditions that give them an equally reduced ability to fight infections and other diseases.

In mid-September, an FDA advisory committee recommended booster shots of the Pfizer-BioNTech vaccine for people ages 65 or older—or for those at high risk of severe COVID-19, a minimum of six months after they received their second shot. The committee also advised against approving a booster of the Pfizer vaccine for anyone ages 16 and older. The FDA is predicted to form a choice supported the advisory committee’s recommendations soon.

Approved for adults ages 16 and older within the U.S., with EUA for ages 12-15, and for specified age groups in other countries, including within the European Union (under the name Comirnaty).

Two shots, 21 days apart; fully effective fortnight after second shot.

Effectiveness:

Experts still study Pfizer’s efficacy both within the laboratory and within the world . Pfizer’s initial Phase 3 clinical data presented in December showed its vaccine to possess 95% efficacy.

In April, the corporate announced the vaccine had 91.3% efficacy against COVID-19, supported measuring how well it prevented symptomatic COVID-19 infection seven days through up to 6 months after the second dose. It also found it to be 100% effective in preventing severe disease as defined by the CDC, and 95.3% effective in preventing severe disease as defined by the FDA. Another study, not yet peer-reviewed, provided more new data that brought the efficacy number right down to 84% after 6 months, although efficacy against severe disease was 97%.

In August, the CDC also published studies that showed mRNA vaccine protection against infection could also be waning, although the vaccines were still highly effective against hospitalization. In one CDC study, data from the state of latest York showed vaccine effectiveness dropping from 91.7 to 79.8% against infection.

Side Effects:

Chills, headache, pain, tiredness, and/or redness and swelling at the injection site, all of which generally resolve within each day or two of rest, hydration, and medications like acetaminophen. (If symptoms don’t resolve within 72 hours or if you've got respiratory symptoms, like cough or shortness of breath, call your doctor.) On rare occasions, the vaccine has seemed to trigger anaphylaxis, a severe reaction that's treatable with epinephrine (the drug in Epipens®). For that reason, the Centers for Disease Control and Prevention (CDC) requires vaccination sites to watch everyone for quarter-hour after their COVID-19 shot and for half-hour if they need a history of severe allergies.

Working Method:

Unlike vaccines that put a weakened or inactivated disease germ into the body, the Pfizer mRNA vaccine delivers a small piece of ordering from the SARS CoV-2 virus to host cells within the body, essentially giving those cells instructions, or blueprints, for creating copies of spike proteins. The spikes do the work of penetrating and infecting host cells. These proteins stimulate an immune reaction , producing antibodies and developing memory cells which will recognize and respond if the body is infected with the particular virus.

More Detail

Read More

Detail Of COVID-19 Vaccine and How it works and its effects and side effects

 Corona Virus Vaccine

Introduction:

All the ingredients of a vaccine play a crucial role in ensuring a vaccine is safe and effective. a number of these include:

The antigen. this is often a killed or weakened sort of an epidemic or bacteria, which trains our bodies to acknowledge and fight the disease if we encounter it within the future.

Adjuvants, which help to spice up our immune reaction . this suggests they assist vaccines to figure better.

Preservatives, which ensure a vaccine stays effective.

Stabilisers, which protect the vaccine during storage and transportation.

Vaccine ingredients can look unfamiliar once they are listed on a label. 

However, many of the components utilized in vaccines occur naturally within the body, within the environment, and within the foods we eat. All of the ingredients in vaccines – also because the vaccines themselves - are thoroughly tested and monitored to make sure they're safe.

Effectiveness:

Vaccination is safe and side effects from a vaccine are usually minor and temporary, like a sore arm or mild fever. More serious side effects are possible, but extremely rare.

Any licensed vaccine is rigorously tested across multiple phases of trials before it's approved to be used and frequently reassessed once it's introduced. Scientists also are constantly monitoring information from several sources for any sign that a vaccine may cause health risks.

Remember, you're much more likely to be seriously injured by a vaccine-preventable disease than by a vaccine. for instance , tetanus can cause extreme pain, muscle spasms (lockjaw) and blood clots, measles can cause encephalitis (an infection of the brain) and blindness. Many vaccine-preventable diseases can even end in death. the advantages of vaccination greatly outweigh the risks, and lots of more illnesses and deaths would occur without vaccines.

Working Detail:

Vaccines reduce risks of getting a disease by working together with your body’s natural defenses to create protection. once you get a vaccine, your system responds. It:

Recognizes the invading germ, like the virus or bacteria.

Produces antibodies. Antibodies are proteins produced naturally by the system to fight disease.

Remembers the disease and the way to fight it. If you're then exposed to the germ within the future, your system can quickly destroy it before you become unwell.

The vaccine is therefore a secure and clever thanks to produce an immune reaction within the body, without causing illness.

Our immune systems are designed to recollect . Once exposed to at least one or more doses of a vaccine, we typically remain protected against a disease for years, decades or maybe a lifetime. this is often what makes vaccines so effective. instead of treating a disease after it occurs, vaccines prevent us within the first instance from getting sick.

More Detail

Read More

Symptoms and Treatment of Corona virus (COVID 19)

COVID-19 affects different people in different ways.
Mostly people will  recover without hospitalization.

Most Common Symptoms:

fever

cough

tiredness

loss of taste or smell.

Less common symptoms:

sore throat

headache

aches and pains

diarrhoea

a rash on skin, or discolouration of fingers or toes

red or irritated eyes.

Serious symptoms:

difficulty breathing or shortness of breath

loss of speech or mobility, or confusion

chest pain.

Seek immediate medical attention if you've got serious symptoms. Always call before visiting your doctor or clinic . 

People with mild symptoms who are otherwise healthy should manage their symptoms reception . 

On average it takes 5–6 days from when someone is infected with the virus for symptoms to point out , however it can take up to 14 days.

Treatment

Self care

After exposure to someone who has COVID-19, do the following:

Call your health care provider or COVID-19 hotline to seek out out where and when to urge a test.

Cooperate with contact-tracing procedures to prevent the spread of the virus.

If testing isn't available, stay home and faraway from others for 14 days.

While you're in quarantine, don't attend work, to high school or to public places. Ask someone to bring you supplies.

Keep a minimum of a 1-metre distance from others, even from your relations .

Wear a medical mask to guard others, including if/when you would like to hunt medical aid .

Clean your hands frequently.

Stay during a separate room from other relations , and if impossible , wear a medical mask.

Keep the space well-ventilated.

If you share an area , place beds a minimum of 1 metre apart.

Monitor yourself for any symptoms for 14 days.

Call your health care provider immediately if you've got any of those danger signs: difficulty breathing, loss of speech or mobility, confusion or pain .

Stay positive by keeping in-tuned with loved ones by phone or online, and by exercising reception .

Medical Treatments

Scientists round the world are working to seek out and develop treatments for COVID-19.

Optimal supportive care includes oxygen for severely ill patients and people who are in danger for severe disease and more advanced respiratory support like ventilation for patients who are critically ill.

Dexamethasone may be a corticosteroid which will help reduce the length of your time on a ventilator and save lives of patients with severe and important illness.

More Details......

Read More